文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

免疫功能受损ARDS患者的呼吸力学与结局:EFRAIM研究二次分析

Respiratory Mechanics and Outcomes in Immunocompromised Patients With ARDS: A Secondary Analysis of the EFRAIM Study.
PubMed 文献 · Chest · 2020-06-20
一句话结论免疫功能受损ARDS患者中,驱动压、平台压和呼吸系统顺应性与住院死亡率独立相关,潮气量无此关联。

该研究为EFRAIM数据的预设二次分析,纳入789例符合柏林定义ARDS的患者,其中494例有呼吸力学数据。住院死亡率为56.3%。校正后,驱动压(OR 1.08)、平台压(OR 1.07)升高和呼吸系统顺应性(OR 0.97)降低与住院死亡率显著相关;病因未明、需血管加压药和需肾脏替代治疗也与死亡独立相关。作者认为呼吸力学可提供额外预后信息,可能需设计研究以定义基于这些生理变量的肺保护性通气。

要点

  • 免疫功能受损ARDS患者住院死亡率为56.3%。
  • 校正后驱动压每升高1个单位,住院死亡OR为1.08(95%CI 1.05-1.12)。
  • 校正后平台压每升高1个单位,住院死亡OR为1.07(95%CI 1.04-1.11)。
  • 校正后呼吸系统顺应性每升高1个单位,住院死亡OR为0.97(95%CI 0.95-0.98)。
  • 潮气量与住院死亡率无显著关联;柏林定义ARDS严重度、入院时中性粒细胞减少及基础疾病类型与死亡率无显著关联。

适用人群与场景

  • 免疫功能受损且符合柏林定义ARDS的患者,数据来自EFRAIM研究。
  • 789例符合柏林定义ARDS,其中494例有平台压、驱动压和呼吸系统顺应性数据。

研究设计与关键结果

  • 研究类型为EFRAIM数据的预设二次分析,共789例符合柏林定义ARDS,494例有呼吸力学数据。
  • 住院死亡率为56.3%。
  • 校正后与住院死亡率独立相关的因素:病因未明ARDS(OR 1.66;95%CI 1.01-2.72)、需血管加压药(OR 1.91;95%CI 1.27-2.88)、需肾脏替代治疗(OR 2.02;95%CI 1.37-2.97)。
  • 校正前,较高平台压、较高驱动压和较低呼吸系统顺应性与较高死亡率相关;将各变量分别加入最终分层模型后均显示与死亡率显著相关:驱动压(OR 1.08;95%CI 1.05-1.12)、平台压(OR 1.07;95%CI 1.04-1.11)、呼吸系统顺应性(OR 0.97;95%CI 0.95-0.98)。
  • 潮气量与死亡率无显著关联。
  • 柏林定义ARDS严重度、入院时中性粒细胞减少及基础疾病类型与死亡率无显著关联。

证据类型、等级与局限

  • 证据类型:EFRAIM数据的预设二次分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,在免疫功能受损ARDS患者中,呼吸力学可提供超出住院死亡预测因素的额外预后信息。
  • 作者认为,可能需设计研究以定义基于这些生理变量的肺保护性通气。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: In view of the high mortality rate of immunocompromised patients with ARDS, it is important to identify targets for improvement.

RESEARCH QUESTION: This study investigated factors associated with mortality in this specific ARDS population, including factors related to respiratory mechanics (plateau pressure [Pplat,rs], compliance [Crs], and driving pressure [ΔPrs]).

STUDY DESIGN AND METHODS: This study consisted of a predefined secondary analysis of the EFRAIM data. Overall, 789 of 1,611 patients met the Berlin criteria for ARDS, and Pplat,rs, ΔPrs, and Crs were available for 494 patients. A hierarchical model was used to assess factors at ARDS onset independently associated with hospital mortality.

RESULTS: Hospital mortality was 56.3%. After adjustment, variables independently associated with hospital mortality included ARDS of undetermined etiology (OR, 1.66; 95% CI, 1.01-2.72), need for vasopressors (OR, 1.91; 95% CI, 1.27-2.88), and need for renal replacement therapy (OR, 2.02; 95% CI, 1.37-2.97). ARDS severity according to the Berlin definition, neutropenia on admission, and the type of underlying disease were not significantly associated with mortality. Before adjustment, higher Pplat,rs, higher ΔPrs, and lower Crs were associated with higher mortality. Addition of each of these individual variables to the final hierarchical model revealed a significant association with mortality: ΔPrs (OR, 1.08; 95% CI, 1.05-1.12), Pplat,rs (OR, 1.07; 95% CI, 1.04-1.11), and Crs (OR, 0.97; 95% CI, 0.95-0.98). Tidal volume was not associated with mortality.

INTERPRETATION: In immunocompromised patients with ARDS, respiratory mechanics provide additional prognostic information to predictors of hospital mortality. Studies designed to define lung-protective ventilation guided by these physiological variables may be warranted in this specific population.

来源:Chest,查看原文。版权归原作者所有。

参考来源

  1. Demoule A, Antonelli M, Schellongowski P, et al. Respiratory Mechanics and Outcomes in Immunocompromised Patients With ARDS: A Secondary Analysis of the EFRAIM Study. Chest. 2020. PMID: 32569634. doi:10.1016/j.chest.2020.05.602

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。